What happens to the pleural space affected by malignant effusion after bedside pleurodesis?

被引:2
|
作者
de Araujo, Pedro H. X. N. [1 ]
Terra, Ricardo M. [1 ]
Santos, Thiago da Silva [1 ]
Chate, Rodrigo C. [2 ]
de Paiva, Antonio F. L. [2 ]
Pego-Fernandes, Paulo M. [1 ]
机构
[1] Univ Sao Paulo, Sch Med, Hosp Clin, Thorac Surg Div, Sao Paulo, SP, Brazil
[2] Univ Sao Paulo, Sch Med, Hosp Clin, Div Radiol, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
CT scan; neoplasm; pleural disease; radiology and other imaging; thoracic surgery; TALC PLEURODESIS; POUDRAGE; CT; MANOMETRY; PRESSURE;
D O I
10.1002/jso.25040
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and objectivesEvaluate radiological characteristics of postpleurodesis pleural space of patients with recurrent malignant pleural effusion(RMPE). MethodsProspective cohort study including patients with RPME treated with bedside pleurodesis. We used CT scans to calculate pleural cavity volume immediately before pleurodesis(iCT) and 30 days after(CT30). Radiological evolution was calculated by the difference between pleural volumes on CT30 and iCT(volume). We categorized initial pleural volume as small(<500mL) or large space(500mL) and volume as positive(>254.49mL), unchanged(-268.77-254.49mL), or negative(<-268.77mL). Futhermore, we analyzed clinical effectiveness, pleural elastance, and adverse events. ResultsA total of 87 patients were analyzed. Pleural volume varied from 35-2750mL in iCT and from 0-2995mL in CT30(P=0.753). A total of 54 patients had initial small pleural space(62.06%) and 33 large(37.93%). Clinical failure occurred in 7.4% of small space group and in 24.6% of large(P=0.051, OR4.0(CI:1.098-14.570)). In small space group, 27.77% evolved with positive, 66.66% with unchanged and 5.55% with negative volume. In the large space group these numbers were respectively 21.21%, 27.27%, and 51.51%. ConclusionsThere is significant variability on pleural space volume. However, pleural volume remains unchanged in many cases. Besides that, more than half patients with initial large space coursed with relevant reduction. Finally, patients with initial small space presented a greater chance of clinical success.
引用
收藏
页码:1556 / 1562
页数:7
相关论文
共 50 条
  • [31] MANAGEMENT OF MALIGNANT PLEURAL EFFUSION SECONDARY TO BREAST-CANCER - TALC PLEURODESIS AND PLEUROPERITONEAL SHUNTING
    SAUTE, M
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1995, 31 (2-3): : 160 - 162
  • [32] Treatment of Malignant Pleural Effusion: PleuRx® Catheter or Talc Pleurodesis? A Cost-Effectiveness Analysis
    Olden, Aaron M.
    Holloway, Robert
    JOURNAL OF PALLIATIVE MEDICINE, 2010, 13 (01) : 59 - 65
  • [33] Improved Quality of Life in Patients with Malignant Pleural Effusion Following Videoassisted Thoracoscopic Talc Pleurodesis. Preliminary Results
    Basso, Stefano M. M.
    Mazza, Francesco
    Marzano, Bernardo
    Santeufemia, Davide A.
    Chiara, Giordano B.
    Lumachi, Franco
    ANTICANCER RESEARCH, 2012, 32 (11) : 5131 - 5134
  • [34] Matrix metalloproteinases production in malignant pleural effusions after talc pleurodesis
    D'Agostino, P
    Camemi, AR
    Caruso, R
    Arcoleo, F
    Cascio, A
    Dolce, A
    Sacco, E
    Cangemi, G
    Di Rosa, T
    Moceo, P
    Cillari, E
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 134 (01) : 138 - 142
  • [35] Is Silver Nitrate Pleurodesis for Patients with Malignant Pleural Effusion Feasible and Safe When Performed in an Outpatient Setting?
    Terra, Ricardo Mingarini
    Kim, So Yeon
    Pego-Fernandes, Paulo Manuel
    Teixeira, Lisete Ribeiro
    Vargas, Francisco Suso
    Jatene, Fabio Biscegli
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (04) : 1145 - 1150
  • [36] Talc Pleurodesis as Surgical Palliation of Patients with Malignant Pleural Effusion. Analysis of Factors Affecting Survival
    Lumachi, Franco
    Mazza, Francesco
    Ermani, Mario
    Chiara, Giordano B.
    Basso, Stefano M. M.
    ANTICANCER RESEARCH, 2012, 32 (11) : 5071 - 5074
  • [37] Safety and Systemic Consequences of Pleurodesis with Three Different Doses of Silver Nitrate in Patients with Malignant Pleural Effusion
    Terra, Ricardo Mingarini
    Bellato, Renato Tavares
    Teixeira, Lisete Ribeiro
    Chate, Rodrigo Caruso
    Pego-Fernandes, Paulo Manuel
    RESPIRATION, 2015, 89 (04) : 276 - 283
  • [38] Comparison of Success Rates of Pleurodesis with Talc, and Holmium-YAG Laser in the Patients with Malignant Pleural Effusion
    Ulusan, Ahmet
    Sanli, Maruf
    Arslan, Ersin
    Isik, Ahmet Feridun
    Tuncozgur, Bulent
    Kul, Seval
    Dikensoy, Oner
    Elbeyli, Levent
    EUROPEAN JOURNAL OF THERAPEUTICS, 2019, 25 (02): : 115 - 120
  • [39] What You Need to Know About: The Management of Malignant Pleural Effusion
    Scott, Hainey
    Phil, Reid
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2024, 85 (12)
  • [40] Talc pleurodesis versus indwelling pleural catheter among patients with malignant pleural effusion: a meta-analysis of randomized controlled trials
    Wang, Li
    Deng, Huan
    Chen, Xinling
    Li, Can
    Yi, Fengming
    Wei, Yiping
    Zhang, Wenxiong
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2020, 18 (01)